Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letetresimab and azacitidine in recurrent AML after transplantation
NCT05266274Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Open-label trial of lemzoparlimab in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
lemzoparlimab
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05266274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266274.